Inventor · disambiguated record
Philipp Steiner
Also filed as: STEINER PHILIPP
6 granted patents·7 pending applications·41 citations·filing 2012–2024
78Inventor score
Files withMEDIMMUNE LLC4TRIEZA THERAPEUTICS INC4WEREWOLF THERAPEUTICS INC3BEDIAN VAHE1POTENZA THERAPEUTICS INC1
Top patents by PatentIndex Score
13 records- 0191US10232053B2Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancerTRIEZA THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·23 cites·5 claims
- 0287US9220775B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Dec 29, 2015·15 cites·39 claims
- 0379US10040857B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 7, 2018·3 cites·56 claims
- 0468US2021393803A1Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancerTRIEZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0565US11091554B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2018·Granted Aug 17, 2021·0 cites·20 claims
- 0665US2024216505A1Inducible cytokine prodrug and pd-1/pd-l1 combination therapyWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0765US2024216474A1Activatable interferon polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0861US2020014798A1Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancerTRIEZA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0960US2024043488A1Activatable il-12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1052US11305012B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Apr 19, 2022·0 cites·14 claims
- 1152US2019142967A1Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of CancerTRIEZA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1240US11453720B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·0 cites·21 claims
- 1339US2014314784A1Anti-cxcr4 antibodies and methods of useBEDIAN VAHE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philipp Steiner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →